Boulder, CO, United States of America

Eileen Spindler

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 118(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Eileen Spindler: Pioneering Innovations in Genetic Editing

Introduction

Eileen Spindler, a trailblazing inventor based in Boulder, Colorado, has made significant contributions to the field of genetic editing. With a robust portfolio of 14 patents, she is recognized for her innovative approaches that enhance the efficiency and effectiveness of gene editing technologies.

Latest Patents

Among her most recent patents is the groundbreaking work titled "Detection of Nuclease Edited Sequences in Automated Modules and Instruments." This patent focuses on providing modules and instruments designed to enrich for cells that have been edited via nucleic acid-guided nuclease editing of live cells. Another notable patent is "Methods for Increasing Observed Editing in Bacteria," which explores techniques to increase observed editing rates in surviving bacterial cells. This discovery has led to an impressive phenomenon where 75% of surviving cells from a particular experiment were multiple editors that had undergone edits at multiple locations within their genomes.

Career Highlights

Eileen currently lends her expertise to Inscripta, Inc., a company dedicated to advancing the future of genetic engineering. In her role, she is at the forefront of developing technologies that facilitate precision editing, helping to transform the landscape of biotechnology.

Collaborations

Throughout her career, Eileen has collaborated with esteemed colleagues such as Tian Tian and Charles D. Johnson. These partnerships have been instrumental in advancing her research and in bringing innovative solutions to the scientific community.

Conclusion

Eileen Spindler stands out as a remarkable inventor whose work is shaping the future of genetic editing. Her patents reflect not only her dedication to innovation but also her commitment to enhancing our understanding and capabilities in genetic engineering. As she continues her pioneering work at Inscripta, the impact of her contributions in the field is poised to grow further.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…